# teduglutide (teduglutide) by Patheon Italia S.p.A.: new drug for further processing listing

**Launch Signal Score:** 25/100

| Field | Value |
|---|---|
| Generic name | teduglutide |
| NDC | 68225-265 |
| Labeler | Patheon Italia S.p.A. |
| Product type | DRUG FOR FURTHER PROCESSING |
| Approval pathway | DRUG FOR FURTHER PROCESSING |
| Dosage form | INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION |
| Active ingredients | TEDUGLUTIDE 5 mg/.5mL |
| Marketing start | 2026-09-02 |
| Package configurations | 1 |

## Why this score
- Injectable: hospital and 503B relevance.

Source: U.S. FDA National Drug Code (NDC) Directory via openFDA (https://dailymed.nlm.nih.gov/dailymed/search.cfm?labeltype=all&query=68225-265). Last refreshed: 2026-11-04T18:12:05.743Z.
Listing data comes from the FDA NDC directory via openFDA; a listing is not an FDA approval or endorsement and may be updated or withdrawn. Informational only; not medical advice.